C
Cocrystal Pharma, Inc. (COCP)
NCM – Real vaqt narxi. Valyuta: USD
1.31
+0.01 (0.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.31
+0.01 (0.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington.
| Ism | Lavozim |
|---|---|
| Dr. Sam Lee Ph.D. | Co-Founder, Co-CEO & President |
| Mr. James J. Martin CPA, M.B.A. | Co-CEO, CFO & Corporate Secretary |
| Prof. Roger D. Kornberg Ph.D. | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 8-K | form8-k.htm |
| 2026-04-23 | S-3 | forms-3.htm |
| 2026-04-02 | 8-K | form8-k.htm |
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-03-31 | 10-K | form10-k.htm |
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-03-09 | 8-K | form8-k.htm |
| 2026-02-19 | 8-K | form8-k.htm |
| 2026-01-15 | 8-K | form8-k.htm |
| 2025-12-18 | 8-K | form8-k.htm |